DNM2 and centronuclear myopathy: Furthermore, in a mouse model of autosomal dominant centronuclear myopathy (AD-CNM), treatment with allele-specific siRNAs at advanced stages of the disease reduced around 40% of the mutant DNM2 allele expression and partially rescued the muscle force impairment and morphologic abnormalities [33].